Shim; Hyunsuk

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shim; Hyunsuk.The latest application filed is for "methods of managing vascular conditions and diabetic peripheral neuropathies".

Company Profile

8.8.19

Shim; Hyunsuk - Seoul KR
Shim; Hyunsuk - Atlanta GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Luggage with support Grant 11,375,788 - Shim , et al. July 5, 2	2022-07-05
Methods of Managing Vascular Conditions and Diabetic Peripheral Neuropathies App 20220168300 - Yoon; Young-sup ; et al.	2022-06-02
Chimeric Compounds and Methods of Managing Neurological Disorders or Conditions App 20220133892 - Shim; Hyunsuk ; et al.	2022-05-05
Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction Grant 11,285,151 - Natchus , et al. March 29, 2	2022-03-29
Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction App 20220040174 - Natchus; Michael G. ; et al.	2022-02-10
Luggage With Support App 20220039529 - SHIM; Hyunsuk ; et al.	2022-02-10
Systems and Methods for Rapidly Determining One or More Metabolite Measurements from MR Spectroscopy Data App 20220018922 - Shim; Hyunsuk ; et al.	2022-01-20
Tricyclic Amino Containing Compounds For Treatment Or Prevention Of Symptoms Associated With Endocrine Dysfunction App 20210401836 - Natchus; Michael G. ; et al.	2021-12-30
Bis-amines, Compositions, and Uses Related to CXCR4 Inhibition App 20200316040 - Shim; Hyunsuk ; et al.	2020-10-08
Bis-amines, compositions, and uses related to CXCR4 inhibition Grant 10,709,697 - Shim , et al.	2020-07-14
Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition Grant 10,669,270 - Shim , et al.	2020-06-02
Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction Grant 10,632,120 - Natchus , et al.	2020-04-28
Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction App 20190381042 - Natchus; Michael G. ; et al.	2019-12-19
Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction App 20190374541 - Natchus; Michael G. ; et al.	2019-12-12
Methylsulfonamide derivatives and uses related thereto Grant 10,434,195 - Shim , et al. O	2019-10-08
Amide-Sulfamide Derivatives, Compositions, and Uses Related to CXCR4 Inhibition App 20190084980 - Shim; Hyunsuk ; et al.	2019-03-21
Bis-amines, Compositions, and Uses Related to CXCR4 Inhibition App 20190008840 - Shim; Hyunsuk ; et al.	2019-01-10
Methylsulfonamide Derivatives and Uses Related Thereto App 20180228924 - Shim; Hyunsuk ; et al.	2018-08-16
CXCR4 Antagonists for the Treatment of Medical Disorders App 20160002174 - Shim; Hyunsuk ; et al.	2016-01-07
Cxcr4 Antagonists For The Treatment Of Medical Disorders App 20140039187 - Shim; Hyunsuk ; et al.	2014-02-06
Cxcr4 Antagonists For Imaging Of Cancer And Inflammatory Disorders App 20120294803 - Shim; Hyunsuk ; et al.	2012-11-22
CXCR4 antagonists for the treatment of medical disorders Grant 8,114,884 - Shim , et al. February 14, 2	2012-02-14
CXCR4 antagonists for the treatment of HIV infection Grant 8,008,312 - Shim , et al. August 30, 2	2011-08-30
Compositions and methods for imaging expression of cell surface receptors App 20070258893 - Shim; Hyunsuk ; et al.	2007-11-08
CXCR4 antagonists for the treatment of medical disorders App 20070054930 - Shim; Hyunsuk ; et al.	2007-03-08
CXCR4 antagonists for the treatment of HIV infection App 20060264451 - Shim; Hyunsuk ; et al.	2006-11-23

Company Registrations

NCAGE Code	45PV8	SHIM HYUNSUK
CAGE Code	45PV8	SHIM, HYUNSUK

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.